We found that PYJ alleviates PID by inhibiting protein kinase B (Akt)/nuclear factor kappa-B (NF-κB) pathway and thus reducing the production of pro-inflammatory mediators and macrophage activation. This evidence concerns the gene AKT1 and pelvic inflammatory disease.